Can a complete blood count (CBC) detect liver cancer?
Complete blood count (CBC) is a fundamental clinical test. By measuring and analyzing the qualitative and quantitative characteristics of formed elements in blood, it aids in the diagnosis and management of various diseases. It primarily provides a comprehensive analysis of parameters related to the red blood cell system, white blood cell system, and platelet system, serving as a commonly used indicator for disease diagnosis, treatment, and follow-up. Can a CBC detect hepatocellular carcinoma (HCC)?
Can a CBC detect hepatocellular carcinoma?
A CBC cannot be used to diagnose hepatocellular carcinoma. Although some HCC patients may exhibit abnormalities on CBC—such as elevated or decreased white blood cell counts, anemia, or thrombocytopenia or thrombocytosis—these changes may also result from other underlying conditions. Conversely, some HCC patients may have entirely normal CBC results. Therefore, CBC is not a diagnostic tool for HCC.
Currently, HCC diagnosis relies primarily on tumor marker testing and imaging studies.
First, tumor marker testing typically includes measurement of carbohydrate antigen 19-9 (CA19-9) and abnormal prothrombin (des-gamma-carboxy prothrombin, DCP).
Second, imaging studies include liver ultrasound, contrast-enhanced computed tomography (CT), contrast-enhanced magnetic resonance imaging (MRI), contrast-enhanced ultrasound (CEUS), or gadoxetic acid–enhanced MRI (e.g., Primovist® MRI), with selection based on individual clinical circumstances.

How to prevent hepatocellular carcinoma
1. Prevention and control of viral hepatitis: Since the 1990s, China has implemented nationwide hepatitis B vaccination for newborns. As a result, the national hepatitis B virus infection rate has significantly declined. Continued vigilance and improvement of preventive measures remain essential to avoid missed opportunities for prevention.
2. Improvement of living environment: Enhance water quality standards to ensure rural residents have access to clean, safe tap water; prevent ingestion of mold-contaminated food.
3. Active management of underlying liver disease: Patients diagnosed with chronic hepatitis B or C infection, hepatic fibrosis, or cirrhosis should receive timely antiviral and hepatoprotective therapy to suppress viral replication and disease progression. Regular follow-up monitoring and surveillance are crucial to detect early malignant transformation.
We hope the above information is helpful to you.